Tech Company Financing Transactions
Zurex Pharma Funding Round
Zurex Pharma closed a $6 million Series C investment round on 8/15/2016. Investors included private investors.
Transaction Overview
Company Name
Announced On
8/15/2016
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series C
Investors
Proceeds Purpose
Zurex intends to use the funds to support pivotal Phase III clinical trials of its lead compound and for general corporate and working capital purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2113 Eagle Dr.
Middleton, WI 53562
USA
Middleton, WI 53562
USA
Phone
Website
Email Address
Overview
Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Frederick Robertson
Chief Executive Officer
Carmine Durham
Chief Financial Officer
Alex Kasper
VP - Regulatory Affairs
Andrew Morgan
Browse more venture capital transactions:
Prev: 8/15/2016: Unify Water venture capital transaction
Next: 8/15/2016: NoWait venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs